The arrival of Retatrutide ZPHC, at a dosage of 120mg, is creating considerable buzz within the medical community. This innovative dual GIP and GLP-1 agonist medication seems to provide notable improvements in weight shedding compared to previous therapies. Early patient studies have indicated significant decreases in body fat percentage, conceivab